Skip to content
Fast Company1 min read

Wegovy’s new pricing could save you $1,200—but...

Novo Nordisk just launched a new subscription program for Wegovy customers. In an announcement Tuesday, the Danish GLP-1 maker said the new program will help “reduce cost uncertainty” so that people can maintain access to their obesity drugs. Wegovy contains semaglutide, a glucagon-like peptide-1 receptor agonist used for chronic weight management. Novo Nordisk also promised savings of up to $600 per year for the pill form of the drug and up to $1,200 per year for the injections with a 12-month
Read original on fastcompany.com
0
0

Comment

Sign in to join the discussion.

Loading comments…

Related

r/startups1 min

Linear just announced "Issue Tracking is...

So we've been obsessing over "the moat" at my startup lately. It's the classic question: what actually protects us long-term? Nothing tunes the senses on this like watching somene else's moat disappear. In our weekly eng meeting, we were figuring out how to handle customer bug reports post-launch. One idea was routing them straight to Linear for triage. Normal stuff. We tabled it. More important stuff to do. Here's the thing though, my co-founder has basically stopped using Linear. We have a coo

reddit.com
19
9
Stratechery

Spring Break

Stratechery is on a bit of a disjointed Spring Break, as my usual week off will be spread out: I will return to my usual posting schedule on Tuesday, March 31. All other Stratechery Plus content, including my podcasts, will stay on schedule.

stratechery.com
0
0

Get the 10 best reads every Sunday

Curated by AI, voted by readers. Free forever.

Liked this? Start your own feed.

0
0